NCT06099730View on ClinicalTrials.gov

Safety and Effectiveness of Pulmonary Vein isOLation And posterioR Wall Ablation wIth pulSed Field Energy in Patients With Paroxysmal and Persistent AF

NAActive, not recruitingINTERVENTIONAL
Enrollment

360

Participants

Timeline

Start Date

December 14, 2023

Primary Completion Date

November 30, 2026

Study Completion Date

November 30, 2026

Conditions
Atrial Fibrillation
Interventions
DEVICE

Pulsed Field Ablation (PFA)

PFA using Irreversible Electroporation (IRE) Ablation System

Trial Locations (7)

10029

Mount Sinai Hospital, New York

10467

Montefiore Medical Center, New York

44195

Cleveland Clinic, Cleveland

72401

St. Bernard's Heart and Vascular Center, Jonesboro

78705

Texas Cardiac Arrhythmia Institute/Research Foundation, Austin

02114

Massachusetts General Hospital, Boston

02215

Beth Israel Deaconess Medical Center, Boston

All Listed Sponsors
lead

Massachusetts General Hospital

OTHER

NCT06099730 - Safety and Effectiveness of Pulmonary Vein isOLation And posterioR Wall Ablation wIth pulSed Field Energy in Patients With Paroxysmal and Persistent AF | Biotech Hunter | Biotech Hunter